MA46927A - Procédés de détection du cancer - Google Patents
Procédés de détection du cancerInfo
- Publication number
- MA46927A MA46927A MA046927A MA46927A MA46927A MA 46927 A MA46927 A MA 46927A MA 046927 A MA046927 A MA 046927A MA 46927 A MA46927 A MA 46927A MA 46927 A MA46927 A MA 46927A
- Authority
- MA
- Morocco
- Prior art keywords
- detection methods
- cancer detection
- cancer
- methods
- detection
- Prior art date
Links
Classifications
-
- G01N33/57515—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662425549P | 2016-11-22 | 2016-11-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA46927A true MA46927A (fr) | 2019-10-02 |
Family
ID=62195635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA046927A MA46927A (fr) | 2016-11-22 | 2017-11-22 | Procédés de détection du cancer |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200081008A1 (enExample) |
| EP (1) | EP3544605A4 (enExample) |
| JP (2) | JP2020511933A (enExample) |
| CN (1) | CN110198711A (enExample) |
| CA (1) | CA3044257A1 (enExample) |
| MA (1) | MA46927A (enExample) |
| MX (1) | MX2019006005A (enExample) |
| WO (1) | WO2018098379A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3044257A1 (en) * | 2016-11-22 | 2018-05-31 | Prime Genomics, Inc. | Methods for cancer detection |
| CN108830045B (zh) * | 2018-06-29 | 2021-04-20 | 深圳先进技术研究院 | 一种基于多组学的生物标记物系统筛选方法 |
| KR102211972B1 (ko) * | 2018-08-02 | 2021-02-04 | 엑소젠 피티이. 엘티디 | 액체생검 다중 암 유전자 바이오마커를 이용한 유방암 조기진단 및 치료 후 모니터링 방법 |
| WO2020180896A1 (en) * | 2019-03-03 | 2020-09-10 | Purdue Research Foundation | Systems and methods for identifying subtype, prognosis and monitoring of breast cancer |
| CN111679076A (zh) * | 2020-06-15 | 2020-09-18 | 吉林医药学院 | 一种用于检测cyclinD1和BCL-2抗体的检测试剂盒 |
| US20210388451A1 (en) * | 2020-06-16 | 2021-12-16 | Grail, Inc. | Methods for analysis of cell-free rna |
| CN111979321B (zh) * | 2020-08-26 | 2022-07-12 | 郑州大学第一附属医院 | 用于胰腺癌检查的基因标记物 |
| EP4208712A4 (en) * | 2020-09-01 | 2024-12-11 | Oncodea Corporation | PREDICTIVE DIAGNOSTIC TEST FOR EARLY DETECTION AND MONITORING OF DISEASE |
| CN115927610B (zh) * | 2022-07-19 | 2024-11-05 | 武汉艾米森生命科技有限公司 | 检测foxo6基因中目标区域的甲基化水平的试剂在制备膀胱癌诊断产品中的应用 |
| WO2025005966A1 (en) * | 2023-06-29 | 2025-01-02 | Edge Animal Health, Inc. | Urine pcr assay and use thereof to diagnose and stage feline chronic kidney disease |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6294349B1 (en) * | 1999-03-01 | 2001-09-25 | University Of Mississippi Medical Ctr. | Method of diagnosing and monitoring malignant breast carcinomas |
| US6358683B1 (en) * | 1999-06-03 | 2002-03-19 | The Regents Of The University Of California | Blood-based assays for breast cancer |
| JP2008073304A (ja) * | 2006-09-22 | 2008-04-03 | Gifu Univ | 超音波乳房診断システム |
| GB201000688D0 (en) * | 2010-01-15 | 2010-03-03 | Diagenic Asa | Product and method |
| WO2011100472A1 (en) * | 2010-02-10 | 2011-08-18 | The Regents Of The University Of California | Salivary transcriptomic and proteomic biomarkers for breast cancer detection |
| CA2803266A1 (en) * | 2010-07-08 | 2012-01-12 | Prime Genomics, Inc. | System for the quantification of system-wide dynamics in complex networks |
| WO2012115885A1 (en) * | 2011-02-22 | 2012-08-30 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Circulating biomarkers |
| KR101335034B1 (ko) * | 2011-08-25 | 2013-12-02 | 주식회사 바이오인프라 | 유방암 진단을 위한 엑소좀 내의 ANT2 mRNA의 이용방법 |
| AU2015210886A1 (en) * | 2014-01-29 | 2016-09-01 | Caris Mpi, Inc. | Molecular profiling of immune modulators |
| WO2015187727A2 (en) * | 2014-06-04 | 2015-12-10 | Atossa Genetics Inc. | Molecular mammography |
| WO2016004387A1 (en) * | 2014-07-02 | 2016-01-07 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Gene expression signature for cancer prognosis |
| CA3044257A1 (en) * | 2016-11-22 | 2018-05-31 | Prime Genomics, Inc. | Methods for cancer detection |
-
2017
- 2017-11-22 CA CA3044257A patent/CA3044257A1/en active Pending
- 2017-11-22 MA MA046927A patent/MA46927A/fr unknown
- 2017-11-22 CN CN201780084170.4A patent/CN110198711A/zh active Pending
- 2017-11-22 MX MX2019006005A patent/MX2019006005A/es unknown
- 2017-11-22 EP EP17873722.7A patent/EP3544605A4/en not_active Withdrawn
- 2017-11-22 US US16/462,699 patent/US20200081008A1/en not_active Abandoned
- 2017-11-22 WO PCT/US2017/063157 patent/WO2018098379A1/en not_active Ceased
- 2017-11-22 JP JP2019527223A patent/JP2020511933A/ja active Pending
-
2022
- 2022-07-21 JP JP2022116618A patent/JP2022163076A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020511933A (ja) | 2020-04-23 |
| EP3544605A4 (en) | 2020-11-25 |
| WO2018098379A1 (en) | 2018-05-31 |
| CN110198711A (zh) | 2019-09-03 |
| US20200081008A1 (en) | 2020-03-12 |
| MX2019006005A (es) | 2019-10-02 |
| CA3044257A1 (en) | 2018-05-31 |
| EP3544605A1 (en) | 2019-10-02 |
| JP2022163076A (ja) | 2022-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3443066A4 (en) | METHOD FOR EARLY DETECTING CANCER | |
| IL285838A (en) | Identification using spectroscopy | |
| PL3739299T3 (pl) | Wykrywanie obiektów | |
| EP3408402A4 (en) | MAGNETIC ELECTROCHEMICAL DETECTION | |
| EP3589732A4 (en) | DETECTION OF PROSTATE CANCER | |
| MA46927A (fr) | Procédés de détection du cancer | |
| EP3357000A4 (en) | CANCER IDENTIFICATION SYSTEMS AND METHODS | |
| LT3425055T (lt) | Molekulinis naviko aptikimo/diagnostikos reagentas | |
| DK3538864T3 (da) | Mikrotom | |
| MA55748A (fr) | Procédés de détection d'aav | |
| EP3923593C0 (en) | AREA RECONNAISSANCE | |
| DE112016000423T8 (de) | Abschnittslinienerkennungsvorrichtung | |
| EP2965077A4 (en) | METHOD OF CANCER DETECTION | |
| EP3426241A4 (en) | METHOD FOR THE DIAGNOSIS OF CANCER | |
| EP3488238C0 (en) | COLON CANCER COMBINATION TEST | |
| EP3848709C0 (en) | METHODS FOR DETECTING ESOPHAGEAL CANCER | |
| DK3511705T3 (da) | Detekteringsanordning | |
| EP3607066A4 (en) | PROCEDURE FOR DETECTION OF LUNG CANCER | |
| EP3341496A4 (en) | METHOD FOR DETECTING A CANCER RESIDUAL | |
| BR112017007401A2 (pt) | métodos de detecção específicos | |
| FR3042666B1 (fr) | Detection de signal ultra large bande | |
| EP3610036A4 (en) | DETECTION CASCADES | |
| EP3440641C0 (en) | FRAUD DETECTION | |
| EP3347477A4 (en) | COMPOSITIONS AND PROCEDURES FOR PROTEIN DETECTION | |
| EP3637106A4 (en) | LUNG CANCER DETECTION PROCEDURE |